LPS and cytokine-activated endothelium

Seminars in Thrombosis and Hemostasis

Volumn 26, Issue 5, 2000, Pages 571-587

  Bierhaus, A ^a   Chen, J ^a   Liliensiek, B ^a   Nawroth, P P ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Apoptosis; CD40; Inflammation; NF B; TNF

Indexed keywords

CD40 ANTIGEN; LIPOPOLYSACCHARIDE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; THROMBOSIS; VASCULAR ENDOTHELIUM;

EID: 0033639103     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2000-13214     Document Type: Review

References (208)

1. Self-regulation of procoagulant events on the endothelial cell surface
2. Tumor necrosis factor/cachectin interacts with endothelial cell receptors to induce release of interleukin-1
3. Recombinant tumor necrosis factor induces procoagulant activity in cultured human vascular endothelium: Characterization and comparison with the action of interleukin-1
4. Effects of tumour necrosis factor and related cytokines on vascular endothelial cells
5. Human colony-stimulating factors and stromal cell function
6. LPS-stimulated bovine aortic endothelial cells produce IL-1 and IL-6 like activities
7. Cytokine regulation of endothelial cell function
8. Ligation of CD40 activates interleukin 1 beta-converting enzyme (caspase-1) activity in vascular smooth muscle and endothelial cells and promotes elaboration of active interleukin 1 beta
9. Human endothelium as a source of multifunctional cytokines: Molecular regulation and possible role in human disease
10. Cxc chemokine receptor expression on human endothelial cells
11. Effect of lipopolysaccharides on cultured human endothelial cells. Relationship between tissue factor activity and prostacyclin release
12. CD40 ligand on activated platelets triggers an inflammatory reaction in endothelial cells
13. Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40
14. Interleukin 4 induces interleukin 6 production by endothelial cells: Synergy with interferon-gamma
15. Role of IL-6 and its soluble receptor in induction of chemokines and leukocyte recruitment
16. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions
17. Role of the GRO family of chemokines in monocyte adhesion to MM-LDL-stimulated endothelium
18. Human vascular endothelial cells produce tumor necrosis factor-α in response to proinflammatory cytokine stimulation
19. IL-1 stimulates IL-6 production in endothelial cells
20. TL-1, a novel tumor necrosis factor-like cytokine, induces apoptosis in endothelial cells. Involvement of activation of stress protein kinases (stress-activated protein kinase and p38 mitogen-activated protein kinase and caspase-3-like-protease)
21. VEGI, a novel cytokine of the tumor necrosis family is an angiogenesis inhibitor that suppresses the growth of colon carcinoma in vivo
22. NF-κB as frequent target for immunosuppressive and antiinflammatory molecules
23. Nuclear factor-κB: A pivotal transcription factor in chronic inflammatory diseases
24. The nuclear factor-κB/inhibitor of kappa B autoregulatory system and atherosclerosis
25. Proinflammatory signaling: Last pieces in the NF-κB puzzle?
26. NF-κB: Ten years after
27. Function and activation of NF-κB in the immune system
28. NF-kappa B and I kappa B alpha: An inducible regulatory system in endothelial activation
29. Transcriptional regulation of endothelial adhesion molecules: NF-κB and cytokine-inducible enhancers
30. Mechanism of the TNFα mediated induction of endothelial tissue factor
31. Early activation signals in endothelial cells: Stimulation by cytokines
32. Structure and function of lipopolysaccharide binding protein
33. CD14, a receptor for complexes of lipopolysaccharides (LPS) and LPS binding protein
34. The two soluble forms of the lipopolysaccharide receptor, CD14: Characterization and release by normal human monocytes
35. A critical role of monocytes and CD 14 in endotoxin-induced endothelial cell activation
36. Cell-free pool of CD14 mediates activation of transcription factor NF-κB by lipopolysaccharide in human endothelial cells
37. Recognition of endotoxin by cells leading to transmembrane signaling
38. Activation of human endothelial cells by viable or heat-killed gram-negative bacteria requires soluble CD14
39. Activation of endothelial cells by endotoxin: Direct versus indirect pathways and the role of CD14
40. Tumor necrosis factor-alpha and interleukin-1 beta mediate human endothelial cell activation in blood at low endotoxin concentrations
41. Soluble CD14 promotes LPS activation of CD14-deficient PNH monocytes and endothelial cells
42. Differential antibiotic-induced endotoxin release and interleukin-6 production by human umbilical vein endothelial cells (HUVECs): Amplification of the response by coincubation of HUVEC and blood cells
43. Lipopolysaccharide stimulates the tyrosine phosphorylation of mitogen-activated protein kinases p44, p42 and p41 in vascular endothelial cells in a soluble CD14-dependent manner
44. Endotoxin-mediated endothelial cell injury and activation: Role of soluble CD14
45. Phosphatidylinositol 3-kinase-dependent activation of protein kinase c-zeta in bacterial lipopolysaccharide-treated human monocytes
46. Role of ceramide in lipopolysaccharide (LPS)-induced signaling. LPS increases ceramide rather than acting as a structural homolog
47. Bacterial lipopolysaccharide activates nuclear factor-kappa B through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes
48. CD14 enhances cellular response to endotoxin without imparting ligand-specific recognition
49. CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide
50. Novel insights into molecular mechanism of endotoxin shock: Biochemical analysis of LPS receptor signaling in a cell-free system targeting NF-κB and regulation of cytokine production through beta2 integrin in vivo
51. Outside-in signaling by lipopolysaccharide through a tail-less integrin
52. CD11/CD18 and CD14 share a common lipid A signaling pathway
53. Evidence that the receptor for soluble CD14:LPS complexes may not be the putative signal-transducing molecule associated with membrane-bound CD14
54. Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide
55. Signaling events induced by lipopolysaccharide-activated toll-like receptor 2
56. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling
57. Bacterial lipopolysaccharide has structural similarity to ceramide and stimulates ceramide-activated protein kinase in myeloid cells
58. Cytokine-inducible expression in endothelial cells of an I kappa B alpha-like gene is regulated by NF kappa B
59. Nuclear uptake control of NF-kappa B by MAD-3, an I kappa B protein present in the nucleus
60. Role of NF-κB in the mortality of sepsis
61. Bacterial lipopolysaccharide disrupts endothelial monolayer integrity and survival signaling events through caspase cleavage of adherens junction proteins
62. Direct effects of endotoxin on the endothelium: Barrier function and injury
63. Induction of human endothelial cell apoptosis requires both heat shock and oxidative stress responses
64. Apoptotic cell death of vascular endothelial cells and renal tubular cells in the generalized Shwartzman reaction
65. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells
66. Human endothelial cell response to lipopolysaccharide, interleukin-1 and tumor necrosis factor is regulated by protein synthesis
67. Apoptosis inducers endotoxin and Fas-ligation enhance the expression of vascular endothelial growth factor in human endothelial cells
68. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway
69. Cachectin and tumour necrosis factor as two sides of the same biological coin
70. Pilot clinical trial of an anti-TNF alpha monoclonal antibody for the treatment of septic shock
71. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kD TNF receptor (CD 120a)-Ig fusion protein, Ro 45-2081
72. Combined inhibition of interleukin-1 and tumor necrosis factor in rodent endotoxemia: Improved survival and organ function
73. Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection
74. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity, but highly susceptible to infection by Listeria monocytogenes
75. Strategies to restrain the proinflammatory cytokine
76. Recent advances in tumor necrosis factor and CD40 signaling
77. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor
78. Continuous autotropic signaling by membrane-expressed tumor necrosis factor
79. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40
80. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex
81. Cooperation of both TNF receptors in inducing apoptosis: Involvement of the TNF receptor-associated factor binding domain of the TNF receptor 75
82. IκK-1 and IκK-2: Cytokine activated IκB kinases essential for NF-κB activation
83. Identification of signal-induced IκBα-kinases in human endothelial cells
84. IKAP is a scaffold protein of the IkappaB kinase complex
85. IKK-gamma is an essential regulatory subunit of the IkappaB kinase complex
86. Docking IκB kinases
87. The proteasome pathway is required for cytokine-induced endothelial-leukocyte adhesion molecule expression
88. A sustained reduction in IκB-β may contribute to persistent NF-κB activation in human endothelial cells
89. Role of unphosphorylated, newly synthesized IκBβ in persistent activation of NF-κB
90. Endothelial cell inflammatory response to TNFα: Ceramide-dependent and independent mitogen activated protein kinase cascades
91. Cytokine activation of endothelial cells: New molecules for an old paradigm
92. The regulation of AP-1 activity by mitogen-activated protein kinases
93. JNK or IKK, AP-1 or NF-κB, which are the targets for MEK kinase 1 action?
94. The role of jun, Fos and the AP-1 complex in cell proliferation and transformation
95. Cyclic AMP-independent ATF family members interact with NF-κB and function in the activation of the E-selectin promoter in response to cytokines
96. Lipopolysaccharide induces disseminated endothelial apoptosis requiring ceramide generation
97. FADD, a novel death domain-containing protein interacts with the death domain of Fas and initiates apoptosis
98. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor-1 signal transduction pathways
99. Activation and injury of endothelial cells by cytokines
100. Basic fibroblast growth factor protects endothelial cells against radiation-induced programmed cell death in vitro and in vivo
101. CD40 and CD40 ligand (CD154) are coexpressed on microvessels in vivo in human cardiac allograft rejection
102. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: Implications for CD40-CD40 ligand signaling in atherosclerosis
103. CD40 signalling in vascular cells: A key role in atherosclerosis?
104. Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals
105. CD40 engagement on endothelial cells promotes tissue factor dependent procoagulant activity
106. Expression of functional CD40 by vascular endothelial cells
107. Cytokine-inducible CD40 gene expression in vascular smooth muscle cells is mediated by nuclear factor κB and signal transducer and activator of transcription-1
108. Soluble factors, including TNFα, secreted by human T cells are both cytotoxic and cytostatic for medulloblastoma cells
109. + T cells through LFA-3-mediated stabilization of mRNA
110. Immunobiology of human vascular endothelium
111. Specificities of CD40 signaling: Involvement of TRAF2 in CD40 induced NF-κB activation and intercellular adhesion molecule-1 up-regulation
112. Two differently regulated nuclear factor κB activation pathways triggered by the cytoplasmic tail of CD40
113. IFN-gamma is a potent inducer of Ig secretion by sort-purified murine B cells activated through the mIg, but not the CD40, signaling pathway
114. Phosphorylation of TRAF2 inhibits binding to the CD40 cytoplasmic domain
115. CD40 signaling through tumor necrosis factor receptor-associated factors (TRAFs). Binding site specificity and activation of downstream pathways by distinct TRAFs
116. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of c-Jun N-terminal kinase, activation of MAPKAP kinase-2, phosphorylation of I kappa B alpha, and protection of EEHI-231 cells from anti-IgM-induced growth arrest
117. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-κB and Jun N-terminal kinase activation
118. Activation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor and interleukin-1
119. Local administration of antisense phosphorothioate oligonucleotides to the p65 subunit of NF-kappa B abrogates established experimental colitis in mice
120. Activation of nuclear factor kappa B inflammatory bowel disease
121. Cell specific effects of glucocorticoid treatment on the NF-κBp65/IκBα system in patients with Crohn's disease
122. Expression of CD40 and its ligand, CD40L, in intestinal lesions of Crohn's disease
123. Selected cytokines promote the synthesis of platelet-activating factor in vascular endothelial cells: Comparison between tumor necrosis factor alpha and beta and interleukin-1
124. Role of PAF and cytokines in microvascular tissue injury
125. The glycoprotein Ib-IX-V-complex in platelet adhesion and signaling
126. New concepts in coagulation
127. The relevance of blood cell-vessel wall adhesive interactions for vascular thrombotic disease
128. CD40L-CD40 interactions regulate endothelial cell surface tissue factor and thrombomodulin
129. Inducible endothelial functions in inflammation and coagulation
130. Endothelial leukocyte adhesion molecule 1: An inducible receptor for neutrophils related to complement regulatory proteins and lectins
131. VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4 fibronectin binding site
132. Endothelial interferon regulatory factor 1 cooperates with NF-κB as a transcriptional activator of vascular adhesion molecule 1
133. Coupling of the adhesive receptor CD11b/CD18 to functional enhancement of the effector macrophage tissue factor response
134. 4 integrin chains
135. Modulation of endothelial cell hemostatic properties by tumor necrosis factor
136. Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity
137. Initiation of coagulation by tissue factor
138. Tumor necrosis factor enhances expression of tissue factor mRNA in endothelial cells
139. Cell biology of tissue factor, the principal initiator of blood coagulation
140. Regulation of the tissue factor promoter in endothelial cells
141. Antiparasitic treatment of patients with P. falciparum malaria reduces the ability of patient serum to induce tissue factor by decreasing NF-κB activation
142. Transcriptional regulation of tissue factor expression in human endothelial cells
143. Regulation of the tissue factor gene
144. The dietary pigment curcumin reduces endothelial tissue factor expression by inhibiting binding of AP-1 to the DNA and activation of NF-κB
145. In situ detection of tissue factor in vascular endothelial cells: Correlation with the malignant phenotype of human breast disease
146. Intravenous somatic gene transfer with antisense tissue factor restores blood flow by reducing tumor necrosis factor induced tissue factor expression and fibrin deposition in mouse Meth-A sarcomas
147. Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice
148. Tissue factor expression by endothelial cells in sickle cell anemia
149. Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis
150. Disseminated intravascular coagulation in rabbits induced by administration of LPS or tissue factor: Effect of anti-tissue factor antibodies and measurement of plasma extrinsic pathway inhibitor activity
151. Pathogenesis of disseminated intravascular coagulation in sepsis
152. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys
153. Tumor necrosis factor/cachectin-induced intravascular fibrin formation in Meth A fibrosarcomas
154. Vascular permeability factor: A tumor derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration
155. A polypeptide factor produced by fibrosarcoma cells that induce endothelial tissue factor and enhances the procoagulant response to tumor necrosis factor/cachectin
156. Thrombin activates nuclear factor-kappa B and potentiates endothelial cell activation by TNF
157. Vascular origin of Kaposi's sarcoma. Expression of leukocyte adhesion molecule-1, thrombomodulin, and tissue factor
158. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice
159. Ets transcription factor binding site is required for positive and TNF alpha-induced negative promoter regulation
160. Functional characterization of the 5'-regulatory region of the human thrombomodulin gene
161. Organization and chromosomal localization of the human endothelial protein C receptor gene
162. Interaction of AP-1-, AP-2-, and Sp1-like proteins with two distinct sites in the upstream regulatory region of the plasminogen activator inhibitor-1 gene mediates the phorbol 12-myristate 13-acetate response
163. The protein C pathway: New insights
164. The roles of protein C and thrombomodulin in the regulation of blood coagulation
165. Tumor necrosis factor suppresses transcription of the thrombomodulin gene in endothelial cells
166. Release of thrombomodulin from endothelial cells by a concerted action of TNFα and neutrophils: In vitro and in vivo studies
167. Endothelial protein C receptor
168. Epidemic meningococcemia and purpura fulminans with induced protein C deficiency
169. Protein C prevents the coagulopathic and lethal effects of Escherichia coli infusion in the baboon
170. E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
171. The anticoagulants protein C and protein S display potent antiinflammatory and immunosuppressive effects relevant to transplant biology and therapy
172. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor
173. The up-regulation of IL-6 and IL-8 in human endothelial cells by activated protein C
174. Inhibition of LPS-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees
175. Endotoxin enhances tissue factor and suppresses thrombomodulin expression of human vascular endothelium in vitro
176. Tumor necrosis factor (TNF) stimulates plasminogen activator inhibitor (PAI) production by endothelial cells and decreases blood fibrinolytic activity in the rat
177. Variation in plasminogen-activator-inhibitor-1 gene and risk of meningococcal septic shock
178. A comparison between activated protein C and des-1-41-light chain activated protein C in reactions with type-1 plasminogen activator inhibitor
179. 4G/5G promoter polymorphism in the plasminogen-activator-inhibitor-1 gene and outcome of meningococcal disease
180. Molecular cloning of genes differentially regulated by TNF-α in bovine aortic endothelial cells, fibroblasts and smooth muscle cells
181. Identification of four genes in endothelial cells whose expression is affected by tumor cells and host immune status: A study in ex vivo-isolated endothelial cells
182. Tumor necrosis factor (TNF)-alpha and interleukin (IL)-1beta down-regulate intercellular adhesion molecule (ICAM)-2 expression on the endothelium
183. Suppression of syndecan-1 expression in endothelial cells by tumor necrosis factor-1
184. TNFα regulation of Fas ligand expression on the vascular endothelium modulates leukocyte extravasation
185. Is extravasation a Fas-regulated process?
186. Fas ligation triggers apoptosis in macrophages but not endothelial cells
187. GAS6 inhibits granulocyte adhesion to endothelial cells
188. Expression of receptor tyrosine kinase Ax1 and its ligand Gas6 in rheumatoid arthritis: Evidence for a novel endothelial cell survival pathway
189. Heme oxygenase-1 is required for mammalian iron reutilization
190. Heme oxygenase: A novel target for the modulation of the inflammatory response
191. Effect of tumor necrosis factor-alpha and interleukin-1 alpha on heme oxygenase-1 expression in human endothelial cells
192. Oxidative stress causes enhanced endothelial cell injury in human heme oxygenase-1 deficiency
193. Role of NF-kappa B in the regulation of ferritin H by tumor necrosis factor-alpha
194. Protective genes expressed in endothelial cell: A regulatory response to injury
195. Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B
196. Vascular endothelial growth factor attenuates leukocyte-endothelium interaction during acute endothelial dysfunction: Essential role of endothelium-derived nitric oxide
197. An essential role of NF-κB in preventing TNFα-induced cell death
198. Adenovirus-mediated expression of a dominant negative mutant of p65/RelA inhibits proinflammatory gene expression in endothelial cells without sensitizing apoptosis
199. NF-κB activation is required for human endothelial cell survival during exposure to tumor necrosis factor-alpha but not to interleukin-1 beta or lipopolysaccharide
200. Paracrine control of endothelial cell survival
201. Lipopolysaccharide induces the antiapoptotic molecules A1 and A20 in microvascular endothelial cells
202. A20 blocks endothelial cell activation through a NF-kappaB-dependent mechanism
203. Activation of sphingosine kinase by tumor necrosis factor-alpha inhibits apoptosis in human endothelial cells
204. Nuclear factor (NF)-kappaB-regulated X-chromosome-linked iap gene expression protects endothelial cells from tumor necrosis factor alpha-induced apoptosis
205. Bcl-2 and Bcl-X1 serve an anti-inflammatory function in endothelial cells through inhibition of NF-κB
206. Suppression of TNFα-induced apoptosis by NF-κB
207. Heparin-binding protein targeted to mitochondrial compartments protects endothelial cells from apoptosis